Very good explanation regarding the Express Scripts situation. I certainly appreciate hearing this from someone of your stature Guts who has been in the industry for 35 years. Clearly it is very advantageous to have investors in scrc who are ACTUALLY IN THE PHARMA INDUSTRY TO GIVE US THEIR VALUABLE INSIGHT.



So the bottom line it seems is that compounding is here to stay and other 3rd party players can pick up the slack and will make $$$$ by the departure of Express Scripts in certain areas.


I am led to believe that we will not see any significant fall off with Sept #s. If we can maintain 4.5m to 5m over the next 6 months or so scrc will have a lot of cash on the books.